RAC 1.34% $1.84 race oncology ltd

In one of the interviews (I think it was Proactive), Dr T...

  1. 919 Posts.
    lightbulb Created with Sketch. 294
    In one of the interviews (I think it was Proactive), Dr T estimated that it would cost about 500M to conduct all those 40 x historical trials.
    RAC inherits all that historical data for free.
    And the MC is only 320M - undervalued.
    Add to that the success of the AML clinical trial, pre-clinal breast cancer results, and City of Hope linking bisantrene to FTO, and you begin to see RAC being undervaled even further.

    Heaps of upside to go...


 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.